VERONICA RIDPATH: Open Payments
NPI 1851825780 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253,355 in 303 payments from 16 companies in 2025. Trend: 2023 $8,984 · 2024 $101,048 · 2025 $253,355
Speaker / faculty: $109,491Honoraria: $90,186Consulting: $28,786Travel & lodging: $18,093Food & beverage: $6,716Education: $84
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 95 | $99,241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 47 | $47,910 |
| Alkermes, Inc. | 64 | $44,121 |
| Neurocrine BioSciences, Inc. | 49 | $38,066 |
| Teva Pharmaceuticals USA, Inc. | 8 | $9,200 |
| ABBVIE INC. | 17 | $8,525 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $5,831 |
| E.R. Squibb & Sons, L.L.C. | 8 | $209 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
Products named: Auvelity, CAPLYTA, LYBALVI, INGREZZA, UZEDY, VRAYLAR, REJOYN, ARISTADA.
Industry payments across SC — which companies pay providers there.
